| (210) | Number of the EPO application | 17754226 |
| (220) | Filing date of the EPO application | 2017.07.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 04/2025, 2025.01.22 |
| (110) | EPO patent number | 3490560 |
| (21) | Number of the application | e 2019 0647 |
| (71) | Name(s) of applicant(s), code of the country | Janssen Pharmaceutica, N.V., BE; |
| (72) | Name(s) of inventor(s), code of the country | GOTTARDIS Marco, US;
HAWKINS Rebecca, PA;
SNYDER Linda, US;
YAMADA Douglas H., US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN Pharmaceutica N.V., BE; |
| (54) | Title of the invention | NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCER |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/454 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2019.07.31 |
| (30) | Priority | 201662368466 P, 2016.07.29, US; 201662369239 P, 2016.08.01, US |
| (86) | International application | PCT/US2017/044413, 2017.07.28 |
| (87) | International publication | WO 2018/023017, 2018.02.01 |